Sign in

First Horizon Corporation FHN

Price 25.0 USD
as of 2026-09-04
59/100
No view
Quality50
Growth46
Balance-sheet strength43
Valuation87
Momentum61
Income87

Composite 59/100; the shares have moved about 21% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Balance-sheet strength ranks 43/100 — a slight mark against it.

Case for

Valuation ranks 87/100 — a strong point in its favour. Income ranks 87/100 — a strong point in its favour. Momentum ranks 61/100 — a slight point in its favour.

Case against

Balance-sheet strength ranks 43/100 — a slight mark against it. Growth ranks 46/100 — a slight mark against it. Quality ranks 50/100 — a slight mark against it.

What the company does First Horizon Corporation (FHN) is a regional bank holding company offering commercial, consumer, wealth management, and specialty banking services, including treasury management, equipment finance, and mortgage origination.

Key financials FHN reports ROE 11.5%, ROA 1.3%, gross/net margins 100.0%/30.2%, revenue growth 8.9%, and EPS growth 20.0%. Dividend yield is 2.5% with a 31.2% payout ratio. Valuation metrics include P/E 12.83 (fwd 12.05) and P/B 1.43.

Stock health The stock shows 3m/6m/12m momentum of 4.97%/6.70%/17.25% and RSI(14) at 50.30, indicating neutral momentum. Sideravia scores quality 64.6, valuation 76.6, and income 80.1, reflecting average quality with attractive valuation.

Price vs fair value The stock trades at a discount to both our fair-value estimate and analyst target. - Price is at an 11.40% discount to our fair-value estimate of 28.34 (fair-value estimate). - Price is at a 9.81% discount to the 12-month target of 27.95 based on 19 analysts (analyst count 19.0). - Recent headlines cite strong earnings growth but question valuation attractiveness (Insider Monkey).

Looking forward Forward P/E of 12.05 and PEG of 1.86 suggest moderate valuation relative to growth. Analysts highlight 20% EPS growth but flag valuation as a concern, contributing to the discount versus targets.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.